Chapter 2 Enhanced biocompatibility and osteogenesis of coralline hydroxyapatite modified by BMP-2 incorporated octacalcium phosphate coating

Xingnan Lin,Tie Liu,E. Hunziker,Q. Hu,Xinhua Sun,Y. Liu
2017-01-01
Abstract:Porous coralline hydroxyapatite (CHA) is a good alternative of autologous bone for the treatment of bone defects. However, it lacks intrinsic osteoinductivity and causes foreign body reactions. Previous studies have shown that coating bone substitutes with a layer of octacalcium phosphate (OCP) into which bone morphogenetic protein 2 (BMP-2) was incorporated, can give osteoinductivity and improve biocompatibility. The purpose of the current study was: (1) to determine whether the biocompatibility of CHA granules could be improved by using an OCP coating layer, functionalized with BMP-2; (2) to compare the osteoinductive efficiency of BMP-2 delivered by a surface-adsorbed depot or by an OCP coating-incorporated depot. CHA granules (0.25g per sample) bearing coating-incorporated depot of BMP-2 (20ug / Sample) together with the controls (CHA bearing adsorbed depot of BMP-2; CHA granules with an OCP coating without BMP-2; pure CHA granules) were implanted subcutaneously in rats (n=6 animals per group). Five weeks later, the implants were retrieved for histomorphometric analysis to quantify the volume of bone, bone marrow, fibrous tissue and foreign body giant cells (FBGCs). The osteoinductive efficiency of BMP-2 and the rates of CHA degradation were also calculated. The group with OCP coating-incorporated depot of BMP-2 had the highest volume of bone, bone marrow and osteoinductive efficacy and the lowest volume of FBGCs. The highest rate of degradation of CHA was found in the group with pure CHA and the lowest in the group with CHA coated by OCP. The biocompatibility of CHA granules was significantly improved by either coating with a layer of OCP or adding BMP-2. BMP-2 incorporated into the OCP coating had significantly higher osteoinductive efficiency than BMP-2 adsorbed directly onto the surface of CHA at ectopic sites in rats.
What problem does this paper attempt to address?